Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Molecular Basis of Tumor Heterogeneity in Endometrial Carcinosarcoma.

Leskela S, Pérez-Mies B, Rosa-Rosa JM, Cristobal E, Biscuola M, Palacios-Berraquero ML, Ong S, Matias-Guiu Guia X, Palacios J.

Cancers (Basel). 2019 Jul 9;11(7). pii: E964. doi: 10.3390/cancers11070964. Review.

2.

Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial.

Martin-Broto J, Stacchiotti S, Lopez-Pousa A, Redondo A, Bernabeu D, de Alava E, Casali PG, Italiano A, Gutierrez A, Moura DS, Peña-Chilet M, Diaz-Martin J, Biscuola M, Taron M, Collini P, Ranchere-Vince D, Garcia Del Muro X, Grignani G, Dumont S, Martinez-Trufero J, Palmerini E, Hindi N, Sebio A, Dopazo J, Dei Tos AP, LeCesne A, Blay JY, Cruz J.

Lancet Oncol. 2019 Jan;20(1):134-144. doi: 10.1016/S1470-2045(18)30676-4. Epub 2018 Dec 18.

PMID:
30578023
3.

What's in a name? Molecular subclassification of sarcomas creates fresh challenges.

Díaz-Martín J, Biscuola M, Benoit J, Marcilla D, Civantos G, de Álava E.

J Pathol. 2019 Apr;247(4):409-412. doi: 10.1002/path.5206. Epub 2019 Jan 16.

PMID:
30474142
4.

Preclinical Efficacy of Endoglin-Targeting Antibody-Drug Conjugates for the Treatment of Ewing Sarcoma.

Puerto-Camacho P, Amaral AT, Lamhamedi-Cherradi SE, Menegaz BA, Castillo-Ecija H, Ordóñez JL, Domínguez S, Jordan-Perez C, Diaz-Martin J, Romero-Pérez L, Lopez-Alvarez M, Civantos-Jubera G, Robles-Frías MJ, Biscuola M, Ferrer C, Mora J, Cuglievan B, Schadler K, Seifert O, Kontermann R, Pfizenmaier K, Simón L, Fabre M, Carcaboso ÁM, Ludwig JA, de Álava E.

Clin Cancer Res. 2019 Apr 1;25(7):2228-2240. doi: 10.1158/1078-0432.CCR-18-0936. Epub 2018 Nov 12.

PMID:
30420447
5.

Molecular genetic heterogeneity in undifferentiated endometrial carcinomas.

Rosa-Rosa JM, Leskelä S, Cristóbal-Lana E, Santón A, López-García MÁ, Muñoz G, Pérez-Mies B, Biscuola M, Prat J, Esther OE, Soslow RA, Matias-Guiu X, Palacios J.

Mod Pathol. 2016 Dec;29(12):1594. doi: 10.1038/modpathol.2016.184. No abstract available.

6.

Molecular genetic heterogeneity in undifferentiated endometrial carcinomas.

Rosa-Rosa JM, Leskelä S, Cristóbal-Lana E, Santón A, López-García MÁ, Muñoz G, Pérez-Mies B, Biscuola M, Prat J, Esther O, Soslow RA, Matias-Guiu X, Palacios J.

Mod Pathol. 2016 Nov;29(11):1390-1398. doi: 10.1038/modpathol.2016.132. Epub 2016 Aug 5. Erratum in: Mod Pathol. 2016 Dec;29(12):1594.

7.

CK19 expression in breast tumours and lymph node metastasis after neoadjuvant therapy.

Vieites B, López-García MÁ, Castilla C, Hernández MJ, Biscuola M, Alfaro L, Atienza MR, Castilla MÁ, Palacios J.

Histopathology. 2016 Aug;69(2):239-49. doi: 10.1111/his.12924. Epub 2016 Feb 25.

PMID:
26708058
8.

Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer.

Díaz-Martín J, López-García MÁ, Romero-Pérez L, Atienza-Amores MR, Pecero ML, Castilla MÁ, Biscuola M, Santón A, Palacios J.

Endocr Relat Cancer. 2015 Jun;22(3):443-54. doi: 10.1530/ERC-14-0456. Epub 2015 Apr 13.

PMID:
25870251
9.

Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistry.

Conde E, Suárez-Gauthier A, Benito A, Garrido P, García-Campelo R, Biscuola M, Paz-Ares L, Hardisson D, de Castro J, Camacho MC, Rodriguez-Abreu D, Abdulkader I, Ramirez J, Reguart N, Salido M, Pijuán L, Arriola E, Sanz J, Folgueras V, Villanueva N, Gómez-Román J, Hidalgo M, López-Ríos F.

PLoS One. 2014 Sep 23;9(9):e107200. doi: 10.1371/journal.pone.0107200. eCollection 2014.

10.

Characterization of human mesenchymal stem cells from ewing sarcoma patients. Pathogenetic implications.

Amaral AT, Manara MC, Berghuis D, Ordóñez JL, Biscuola M, Lopez-García MA, Osuna D, Lucarelli E, Alviano F, Lankester A, Scotlandi K, de Álava E.

PLoS One. 2014 Feb 3;9(2):e85814. doi: 10.1371/journal.pone.0085814. eCollection 2014. Erratum in: PLoS One.2014;9(4):e94455.

11.

ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma.

Romero-Pérez L, López-García MÁ, Díaz-Martín J, Biscuola M, Castilla MÁ, Tafe LJ, Garg K, Oliva E, Matias-Guiu X, Soslow RA, Palacios J.

Mod Pathol. 2013 Nov;26(11):1514-24. doi: 10.1038/modpathol.2013.93. Epub 2013 Jun 7.

12.

Oncogene alterations in endometrial carcinosarcomas.

Biscuola M, Van de Vijver K, Castilla MÁ, Romero-Pérez L, López-García MÁ, Díaz-Martín J, Matias-Guiu X, Oliva E, Palacios Calvo J.

Hum Pathol. 2013 May;44(5):852-9. doi: 10.1016/j.humpath.2012.07.027. Epub 2012 Nov 28.

PMID:
23199529
13.

MicroRNA-200 family modulation in distinct breast cancer phenotypes.

Castilla MÁ, Díaz-Martín J, Sarrió D, Romero-Pérez L, López-García MÁ, Vieites B, Biscuola M, Ramiro-Fuentes S, Isacke CM, Palacios J.

PLoS One. 2012;7(10):e47709. doi: 10.1371/journal.pone.0047709. Epub 2012 Oct 24.

14.

Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis.

Romero-Pérez L, Castilla MÁ, López-García MÁ, Díaz-Martín J, Biscuola M, Ramiro-Fuentes S, Oliva E, Matias-Guiu X, Prat J, Cano A, Moreno-Bueno G, Palacios J.

Hum Pathol. 2013 Feb;44(2):244-54. doi: 10.1016/j.humpath.2012.05.013. Epub 2012 Sep 10.

PMID:
22974476
15.

p16 INK4A positivity identifies endometrial surface papillary syncitial change as a regressive feature associated with desquamation.

Nicolae A, Preda O, Aneiros-Fernández J, Palacios J, Biscuola M, Nogales FF.

Histopathology. 2011 Feb;58(3):483-6. doi: 10.1111/j.1365-2559.2011.03766.x. Epub 2011 Feb 16. No abstract available.

PMID:
21323964
16.

Cutaneous Hodgkin-type lymphoproliferative lesion associated with immunomodulatory therapy for ulcerative colitis.

Vieites B, Avila R, Biscuola M, Carvajo F.

J Cutan Pathol. 2011 May;38(5):443-7. doi: 10.1111/j.1600-0560.2010.01663.x. Epub 2011 Jan 25.

PMID:
21261674
17.

Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma.

Castilla MÁ, Moreno-Bueno G, Romero-Pérez L, Van De Vijver K, Biscuola M, López-García MÁ, Prat J, Matías-Guiu X, Cano A, Oliva E, Palacios J.

J Pathol. 2011 Jan;223(1):72-80. doi: 10.1002/path.2802. Epub 2010 Oct 29.

PMID:
21125666
18.

Reconstruction and functional analysis of altered molecular pathways in human atherosclerotic arteries.

Cagnin S, Biscuola M, Patuzzo C, Trabetti E, Pasquali A, Laveder P, Faggian G, Iafrancesco M, Mazzucco A, Pignatti PF, Lanfranchi G.

BMC Genomics. 2009 Jan 9;10:13. doi: 10.1186/1471-2164-10-13.

19.

Wilms' tumour: a complex enigma to decipher.

Robles-Frías MJ, Biscuola M, Castilla M, López-García MA, Sánchez-Gallego F, Palacios J.

Clin Transl Oncol. 2008 Aug;10(8):457-61. Review.

PMID:
18667375
20.

SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease.

Malerba G, Schaeffer L, Xumerle L, Klopp N, Trabetti E, Biscuola M, Cavallari U, Galavotti R, Martinelli N, Guarini P, Girelli D, Olivieri O, Corrocher R, Heinrich J, Pignatti PF, Illig T.

Lipids. 2008 Apr;43(4):289-99. doi: 10.1007/s11745-008-3158-5. Epub 2008 Mar 5.

PMID:
18320251

Supplemental Content

Loading ...
Support Center